NE
NETRIS PHARMA SAS
Grant-FundedCORDISINHIBITING RESISTANCE TO IMMUNOTHERAPY IN HEAD&NECK CANCER BY TARGETING NETRIN-1
Biotech
NETRIS PHARMA SAS is a private SME recorded in CORDIS in France, with participation in 4 EU research and innovation projects. Its recorded projects include “INHIBITING RESISTANCE TO IMMUNOTHERAPY IN HEAD&NECK CANCER BY TARGETING NETRIN-1”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€9,209,579
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇫🇷France
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
NETRIS PHARMA SAS is a private SME recorded in CORDIS in France, with participation in 4 EU research and innovation projects. Its recorded projects include “INHIBITING RESISTANCE TO IMMUNOTHERAPY IN HEAD&NECK CANCER BY TARGETING NETRIN-1”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
Biotech
Tags:Biotech
Company Info
NETRIS PHARMA SAS Info
Funding
EU Grants€9,209,579